Clinical Trial Update: Decitabine Combined With Gemcitabine in First-line Treatment of AdvancedPancreatic Cancer [NA]

View source ↗

Summary

An update on a first-line trial evaluating decitabine in combination with gemcitabine for advanced pancreatic cancer; no trial outcomes are reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Dacogen (decitabine)
• Gemzar (gemcitabine)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Pancreatic Cancer | NA | Status: UNKNOWN